Discounted Cash Flow (DCF) Analysis Levered
Cassava Sciences, Inc. (SAVA)
$ 84.77
4.88 (+6.10%)
Free Cash Flow
Year A/P | 2013 Actual | 2014 Projected | 2015 Projected | 2016 Projected | 2017 Projected | 2018 Projected | 2019 Projected | 2020 Projected | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected |
| Revenue | 41.12 | - | - | - | - | - | - | - | - | - | - | - | - |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | |||||||||||||
| Operating Cash Flow | -6.95 | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Cash Flow (%) | |||||||||||||
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Capital Expenditure (%) | |||||||||||||
| Free Cash Flow | -6.95 | - | - | - | - | - | - | - | - | - | - | - | - |
Weighted Average Cost Of Capital
| Share price | $ 84.77 |
|---|---|
| Beta | 1.120 |
| Diluted Shares Outstanding | 26.11 |
| Cost of Debt | |
| Tax Rate | 0.00 |
| After-tax Cost of Debt | 5.00% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 11.372 |
| Total Debt | 0.29 |
| Total Equity | 2,212.92 |
| Total Capital | 2,213.21 |
| Debt Weighting | 0.01 |
| Equity Weighting | 99.99 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2013 Actual | 2014 Projected | 2015 Projected | 2016 Projected | 2017 Projected | 2018 Projected | 2019 Projected | 2020 Projected | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected |
| Revenue | 41.12 | - | - | - | - | - | - | - | - | - | - | - | - |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.95 | - | - | - | - | - | - | - | - | - | - | - | - |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -6.95 | - | - | - | - | - | - | - | - | - | - | - | - |
| WACC | |||||||||||||
| PV LFCF | - | - | - | - | - | - | - | - | - | - | - | - | |
| SUM PV LFCF | - |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 11.37 |
| Free cash flow (t + 1) | - |
| Terminal Value | - |
| Present Value of Terminal Value | - |
Intrinsic Value
| Enterprise Value | - |
|---|---|
| Net Debt | -93.21 |
| Equity Value | - |
| Shares Outstanding | 26.11 |
| Equity Value Per Share | - |